Pulmonary Drug Delivery Devices Market Size, Share, Growth, Trends, Production, Consumption, Revenue and Forecast 2020 to 2027

Published Date : Jun 2020 | No. of Pages : 200 Pages | Category : Healthcare

According to Vision Research Reports, the global pulmonary drug delivery devices market was valued at US$ 36,159.9 Mn in 2018 and is projected to expand at a CAGR of 2.9% from 2020 to 2027.

The global pulmonary drug delivery devices market size is expected to reach US$ 46 billion by 2027. Growing prevalence of chronic respiratory diseases is one of the key factors anticipated to accelerate demand for pulmonary drug delivery systems (PDDS) in coming years.

Competitive Landscape

  • The global pulmonary drug delivery devices market is fragmented in terms of number of players. Key players in the global market include Boehringer Ingelheim GmbH, Novartis AG, GlaxoSmithKline plc, AstraZeneca plc, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., MannKind Corporation, F. Hoffmann-La Roche Ltd., Mylan N.V., Omron Corporation, 3M Healthcare, Sunovion Pharmaceuticals, Inc., Koninklijke Philips N.V., PARI GmbH, Nypro Healthcare Inc. (Jabil Circuit Inc.) and other prominent players.
  • Companies strive to maintain their leading position in the market by adopting various business strategies such as merger & acquisition, launch of technically advanced products, and expansion strategy enabled companies to expand their product line and strengthen geographic presence across globe.

Segmentation

  • Market, by Product  
    • Dry Powder Inhaler
    • Metered Dose Inhaler
    • Nebulizers
  • Market, by Application    
    • Asthma
    • COPD
    • Cystic fibrosis
    • Others
  • Market, by Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • E-commerce
  • Market, by Region
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific           
      • China
      • India
      • Japan
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of Middle East & Africa

Key Questions Answered in Global Pulmonary Drug Delivery Devices Market Report

  • What is the scope of growth of product companies in the global pulmonary drug delivery devices Market?
  • What will be the Y-o-Y growth of the global pulmonary drug delivery devices market between 2019 and 2027?
  • What is the influence of growing disease prevalence on the global pulmonary drug delivery devices market?
  • What are the technological advancements for the treatment of the pulmonary drug delivery devices condition?
  • Which region continue to be the most profitable market for pulmonary drug delivery devices market?
  • Which factors are anticipated to hamper the growth of the global pulmonary drug delivery devices market during the forecast period?
  • Which are the leading companies in the global pulmonary drug delivery devices market?

Research Methodology

A unique research methodology has been utilized by VRR to conduct comprehensive research on the growth of the global pulmonary drug delivery devices market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global pulmonary drug delivery devices market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and Market intelligence managers, who contributed to the production of VRR’s study on the pulmonary drug delivery devices market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serve as a validation from the pulmonary drug delivery devices market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global pulmonary drug delivery devices market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching VRRs estimates on future prospects of the global pulmonary drug delivery devices market more reliably and accurately.


Featured Research Reports

  • Featured Research Reports

    Pharmaceutical Water Market Size, Share, Growth, Trends, Company Analysis, Regional Insights and Forecast 2020 - 2027

    Read more...
  • Featured Research Reports

    Biomaterials Market Size, Share, Growth, Trends, Company Analysis, Regional Insights and Forecast 2020 - 2027

    Read more...
  • Featured Research Reports

    Orthopedic Biomaterials Market Size, Share, Growth, Trends, Company Analysis, Regional Insights and Forecast 2020 - 2027

    Read more...
  • Featured Research Reports

    Plasmid DNA Manufacturing Market Size, Share, Growth, Trends, Company Analysis, Regional Insights and Forecast 2020 - 2027

    Read more...
  • Featured Research Reports

    Medical Disposables Market Size, Share, Growth, Trends, Company Analysis, Regional Insights and Forecast 2020 - 2027

    Read more...